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Abstract 
Background: With intensive use of anthelmintic drugs in recent decades, anthelmintic resistance (AR) in horse 
nematodes is becoming a growing issue in many countries. However, there is little available information about the 
parasites, treatment practices or AR in the horse population in Lithuania. The aim of this study was to assess the cur‑
rent situation of AR on horse farms in Lithuania. The study was conducted in 25 stables on horses with a strongyle 
faecal egg count (FEC) of ≥ 200 eggs per gram. A faecal egg count reduction test (FECRT) was performed on each 
farm after administration of ivermectin (IVM) or pyrantel (PYR).
Results: The efficacy of IVM was comparatively high, with 98.8% of 250 horses having a zero egg count 14 days after 
treatment. Two conditions were used to interpret the FECRT results for PYR: firstly, resistance was determined when 
FECR was < 90% and the lower 95% confidence interval (LCL) was < 80%, and secondly when in addition the upper 
confidence level (UCL) was < 95%. Under the first condition, resistance against PYR was found in five stables (25% of 
all tested herds), while when considering the UCL as well, resistance was only detected in two stables (8%). The FEC 
showed a significant (P < 0.01) difference between the treatment and control groups. Only cyathostomin larvae were 
detected in larval cultures derived from strongyle‑positive faecal samples collected 14 days after treatment of a test 
group with PYR.
Conclusions: This in vivo study showed that PYR resistance is prevalent on horse farms in Lithuania, while the effi‑
cacy of IVM still appears to be unaffected. However, further studies of ivermectin resistance are needed. These findings 
should guide the implementation of more sustainable management of strongyle infections in horses in Lithuania.
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Background
Strongylid (family Strongylidae) nematodes, such as 
Strongylus (large strongyles) and cyathostomins (small 
strongyles), are the main internal nematode parasites of 
horses and constitute more than 75% of the total intes-
tinal parasite fauna [1, 2]. Large strongyles, such as the 
highly pathogenic Strongylus vulgaris, are no longer 
commonly found in domestic horses [3, 4]. This has led 
to a shift in the focus of anthelmintic treatment pro-
grammes to the less pathogenic, but more common and 
abundant cyathostomin parasites [5, 6].
The increased resistance of horse nematodes to anthel-
mintic drugs [7] is a matter of concern all over the world. 
The use of uncritical anthelmintic treatment strate-
gies rather than evidence-based treatments may partly 
explain the apparent increase in reports of resistance [5]. 
Resistance to benzimidazole has been reported all over 
the world [8–11], while resistance to pyrantel (PYR) is 
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In other European countries close to Lithuania, the situ-
ation regarding resistance to benzimidazole and pyrantel 
is fairly similar. Resistance to benzimidazole has been 
reported in Poland [15] and Ukraine [16], and resistance 
to pyrantel has been reported in Estonia [17] and Sweden 
[18]. The last time resistance to benzimidazole was con-
firmed in Lithuania was by Vyšniauskas et  al. [19]. Due 
to the appearance of resistance to these two drug classes, 
in the past two decades great reliance has been placed 
on macrocyclic lactones (ML). Reports from France [20], 
Germany [21], Belgium, the Netherlands [22] and the UK 
[23] have revealed a shortened strongyle egg reappear-
ance period (ERP) after treatment with ivermectin or 
moxidectin, which is interpreted as an early indication 
of emerging resistance. The current status of anthelmin-
tic efficacy in domestic horses is of importance for both 
scientists, veterinarians and horse owners, particularly 
because no new drug classes or modes of action have 
been introduced since ivermectin in the 1980s [24].
It is widely accepted that due consideration of the role 
of parasite refugia is key to preserving the efficacy of 
anthelmintic drugs in worm control programmes [25]. 
One way to maximise refugia is to apply selective targeted 
treatment as part of a sustainable equine nematode con-
trol programme [26]. For worm control in adult horses, 
guidelines from the European Scientific Counsel Com-
panion Animal Parasites (ESCCAP) and the American 
Association of Equine Practitioners (AAEP) recommend 
using FEC for surveillance, based on anthelmintic treat-
ment programmes in which only those horses above an 
arbitrary cut-off of typically ≥ 200 eggs per gram (FEC) 
are treated [6, 27]. Alternatively, for adult horses where 
selective treatments are not feasible and particularly con-
cerning worm control in young horses, ESCCAP guide-
lines for strategic treatments aim to reduce treatment 
frequencies and vary the drug classes [27]. To ensure this 
can happen, it is important to have information on the 
actual drug efficacy, which should be regularly assessed 
on each farm by post-treatment efficacy testing.
The widely used test to assess anthelmintic efficacy 
is the in vivo FECRT. The World Association for the 
Advancement of Veterinary Parasitology (WAAVP) has 
issued guidelines for the procedure and calculation of 
FECRT [28]. However, there is no single agreed inter-
pretation of the outcome of FECRT and different recom-
mendations have been made to classify drug efficacy as 
“resistance” or “susceptible”, thus the results obtained in 
different studies cannot always be compared directly [7]. 
WAAVP’s current recommendations advise considering 
the presence of resistance if, firstly, the FECR is < 90% and 
secondly the 95% lower confidence level (LCL) is < 90%. 
Resistance is deemed ‘possible’ if one of the two condi-
tions is met. This accounts for BZ and IVM in sheep and 
goats. For BZ in horses, the cut-off point is set at FECR 
<90% but no LCL value is given [28]. More recently, Lyn-
dal-Murphy et al. [29] have shown that it is important to 
include the 95% upper confidence limit (UCL) when clas-
sifying FECRT results and that the presence of resistance 
can only be confirmed if the UCL is < 95%.
Lithuania is estimated to have a horse population of 
about 15,800 individuals (Lithuanian Animal Registry 
Centre) and these horses travel widely. However, there 
is little information in the Baltic region about anthel-
mintic resistance (AR). There have been very few equine 
parasitology surveys conducted in Lithuania—the last 
study involving equine AR in Lithuania was published 
more than fourteen years ago [19]. As a result, very lit-
tle is known about the anthelmintic efficacy status of 
the various formulations available. Therefore, the aim of 
this study was to provide further information about the 
observed efficacy of frequently used formulations of iver-
mectin and pyrantel against populations of strongylid 
parasites on horse farms in Lithuania.
Methods
The study was carried out between April and November 
2019 in twenty-five stables in the northern (44%), central 
(28%), western (16%) and eastern (12%) regions of Lithu-
ania. Horses on these farms are used for sport, leisure 
riding and breeding.
In order to find comparable results, larger stud farms, 
i.e. with at least 35 horses, were pre-selected from the 
database of the Lithuanian Equestrian Federation (LEF) 
[30]. The initial screening included 707 horses, and fur-
ther studies were performed on the horses that met the 
inclusion criteria, which were strongyle faecal egg counts 
exceeding 200 eggs per gram (EPG). All horses had access 
to pasture and had not received any antiparasitic treat-
ment in the eight weeks prior to the study. A total of 659 
horses met these inclusion criteria.
Faecal samples were analysed quantitatively using a 
modified McMaster technique with a detection threshold 
of 20 EPG [31]. Fresh faecal samples were collected from 
a pen containing one horse within one hour of defecation 
or by rectal extraction, and these were stored at 4 °C and 
processed within 24 h.
Faecal egg count reduction tests (FECRT) were per-
formed on the 659 horses that met the inclusion criteria. 
The efficacy of both drugs was evaluated in accordance 
with the recommendations of the World Association for 
the Advancement of Veterinary Parasitology (WAAVP). 
Anthelmintic resistance in horses was determined as the 
percentage reduction of mean egg counts at 14 days post-
treatment: FECR% = 100 × (1–(X1/X2)(Y1/Y2), where 
X1 and X2 represent the mean pre-treatment and post-
treatment faecal nematode egg counts (FECs) of a treated 
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group, and Y1 and Y2 represent the mean pre-treatment 
and post-treatment FECs of an untreated control group 
respectively [28]. On each farm, the horses selected for 
testing were randomly assigned to three experimental 
groups: group A was treated with IVM (n = 10), group B 
with PYR (n = 10) and group C was the untreated control 
group (n ≥ 5). The numbers of animals in the respective 
treatment groups were based on the recommendation 
that 10 animals per group are considered sufficient to 
detect differences in FEC between groups [28].
The weight of each animal was estimated using a girth 
measuring tape. The anthelmintic dosages and routes 
of application were in accordance with the drug manu-
facturers’ recommendations. IVM (0.2 mg per kg body 
weight) was administered per os using the product 
 Bimectin® (Cross Vetpharm Limited, Ireland) and PYR 
embonate (19 mg per kg body weight) was administered 
per os using the product  Embotape® (Cross Vetpharm 
Limited, Ireland).
FECR was classified using two different sets of methods
Assessment method 1 classified the results as “no resist-
ance”, “suspected resistance” and “confirmed resistance” 
using the observed FECR and LCL, according to the 
WAAVP recommendations [28], which for cattle consid-
ers FECR of < 95% with a 95% LCL of < 90% as “confirmed 
resistance”, while a result where only one of the two cri-
teria is met is considered as “suspected resistance”. These 
recommendations propose a value of < 90% as being 
indicative of resistance in horses, but give no value for 
the 95% LCL. Hence, in line with other recent equine AR 
studies [13, 32], the cut off was set at 90% FECR and the 
95% LCL was set at 80% in this study.
Assessment method 2 used a method similar to that 
advocated by Lyndal-Murphy et  al. [29], classifying the 
parasites as “resistant”, “inconclusive” or “susceptible” 
based on the following conditions: they were “resistant” if 
the observed FECR is below 90%, LCL is below 80% and 
UCL is below 95%, “susceptible” if the observed FECR is 
at/above 90% and LCL is at/above 80%, and “inconclu-
sive” if none of the conditions are met.
Differentiation of third‑stage larvae
Faecal samples collected on each farm on day 14 were 
pooled and processed for coproculture. A minimum 
of 3 g from each strongyle-positive sample were mixed 
together and incubated for 7 days at room temperature 
in the laboratory (24–29  °C) (adding water to maintain 
an adequate moisture level and 4 g of vermiculite). Third-
stage larvae  (L3) were subsequently recovered from the 
coprocultures using the Baermann technique [33]. The 
 L3 larvae were microscopically examined, differentiated 
by morphology characteristics, and identified according 
to Maff [34]. The first 100  L3 larvae, or all  L3 when ≤ 100 
developed  L3 larvae, were identified per sample. They 
were identified by the number, shape and arrangement of 
intestinal cells [35].
Statistical analysis
Data were analysed using the statistical software package 
“SPSS for Windows version 20” and descriptive statistics 
(means, standard deviations, reduction percentages etc.) 
were calculated. ANOVA was used to compare the mean 
EPG of each experimental group. Calculation of the 
arithmetic mean, the percentage of reduction, the 95% 
upper and lower confidence limits, and interpretation of 
the findings was as described by Coles et al. [28]. A prob-
ability (P) value less than 0.05 was used to determine the 
level of significance.
Results
A total number of 707 horses from 25 farms in Lithua-
nia were coprologically examined in 2019. Of these, 659 
horses were used to determine prevalences.
The mean pre-treatment and post-treatment FEC, the 
FECR percentage and the lower and upper 95  % confi-
dence limits for each group of anthelmintic drugs tested 
are summarised in Additional file 1.
On three of the 25 farms (12%), the FECR in the IVM 
and PYR groups was 100%.
Faecal egg count reduction test with ivermectin
A total of 250 horses were treated with IVM and 156 
horses were left untreated as a control group. On 22 of 
the 25 farms (88%), the FECR was 100% after treatment, 
and all the horses in this treatment group had a zero egg 
count on the second visit. Three farms had at least one 
horse with positive egg count of 20 EPG on day 14. The 
FECR on these farms was 99.9% (LCL 99.5%), 99.9% (LCL 
99.7%) and 99.7% (LCL 98.6%) respectively. IVM-treated 
horses had significantly (P < 0.01) lower egg counts than 
the untreated group 14 days after treatment.
Faecal egg count reduction test with pyrantel embonate
A total of 250 horses were treated with PYR and 156 
horses were left untreated as a control group. On three of 
the 25 farms (12%) the FECR was 100%, and on five farms 
(20%) the FECR was < 90% (See Additional file 1). PYR-
treated horses had a lower egg count (P < 0.01) than the 
untreated horses 14 days after treatment.
Interpretation of FECR and 95% CI based on the different 
assessment methods
With the IVM results assessment by methods 1 and 2, 
both methods confirmed that ‘no resistance’ to IVM was 
found on the 25 (100%) farms (Table 1).
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With the PYR results assessment by method 1, ‘con-
firmed resistance’ to PYR was found on five farms (25%), 
‘suspected resistance’ was found on one farm (4%), and 
‘no resistance’ was found on 19 farms (79%). Assess-
ing the results by method 2, two out of the 25 (8%) 
farms were classified as ‘resistant’, sixteen farms (64%) 
as ‘susceptible’, and seven farms (28%) as ‘inconclusive’ 
(Table 1).
All the third-stage larvae isolated from strongyle egg 
positive faecal samples were identified as cyathostomin 
larvae.
Discussion
Control of equine nematodes has relied on benzimida-
zoles (BZ), tetrahydropyrimidines and macrocyclic lac-
tones. The intensive use of anthelmintics has led to the 
development of AR in equine cyathostomins around the 
world [36]. Monitoring of AR in cyathostomin is one of 
the most important topics in equine parasitology, but the 
last study about equine AR in Lithuania was published 
more than fourteen years ago [19].
Of all the screened candidates (n = 707), 93% exceeded 
the value of 200 strongyle EPG, which is considered the 
treatment threshold in most current recommendations 
concerning selective treatment strategies. One of the 
basic principles of selective anthelmintic treatment is a 
consistency of the relative magnitude of strongyle FEC of 
individual horses over time [37, 38]. Therefore, identifica-
tion of high egg shedders within the herd is an essential 
goal [38–40]. It is proposed that the identification of ani-
mals regarded as ‘high egg shedders’ enables farms and 
studs to implement more targeted and/or selective treat-
ment approaches to helminth control [38, 40]. It is known 
that acquisition of information about natural distribution 
patterns will help establish appropriate FEC thresholds at 
which horses should be treated with an effective anthel-
mintic (commonly quoted as 200–250 EPG) [5, 38].
This would achieve the dual goal of controlling induced 
health problems while simultaneously reducing pasture 
contamination [14]. The analysis of the screening FEC 
data pre-FECRT (not shown) in the present survey dem-
onstrated that there was a higher percentage of “high egg 
shedders” (i.e. > 200 EPG) than “low or null egg shedders” 
(i.e. < 200 EPG), thus confirming that current control 
programmes are not ideal and providing further support 
for the value of conducting FECs before planning any 
anthelmintic treatment in a yard. Leaving a proportion of 
horses untreated would maximise the refugia with little 
impact on overall control, as horses with low egg counts 
are not important sources of environmental contamina-
tion. Additionally, egg shedding from untreated animals 
would dilute the presence on the pasture of any eggs shed 
by treated animals possibly infected with resistant popu-
lations. In this way, the selection pressure would be pro-
gressively reduced [12, 14].
This study demonstrated a very high efficacy of IVM on 
reducing helminths in horses in Lithuania. As expected, 
the mean percentage efficacy of IVM in eliminating 
strongyle eggs from animal faeces ranged from 99.7% to 
100% (by FECR) for IVM on all stud farms. On three of 
the 25 farms, FEC≥20 EPG 14 days after treatment, but 
the FECR still indicated a high susceptibility to the drug. 
Comparable results have been described in a Lithuanian 
report in 2006 [19], where a 100% efficacy of IVM against 
strongyle was shown in a group of ten study horses. In 
Estonian investigations, FECR after treating horses with 
IVM was 100% [17], 100% in Latvia [41], 99.9% in Poland 
[42] and 99% in Sweden [18]. However, there have been 
few reports describing incidences of reduced efficacy of 
IVM against cyathostomin nematodes [14, 43, 44]. Indi-
cations of shortened ERP have been found in Germany 
[21], Belgium, the Netherlands [22] and Finland [45]. 
Furthermore, findings repeatedly suggest emerging ML 
resistance in cyathostomins due to reduced ERP follow-
ing IVM and moxidectin treatments [21, 22, 46]. The 
shortened ERPs following IVM and moxidectin treat-
ments have been associated with emerging ML resistance 
by fourth-stage larvae [47]. While resistance to these 
drugs is still not prevalent, proper use of the drugs via 
selective treatment using FEC and continued monitoring 
of efficacy with FECRT is of major importance in slowing 
down the development process of resistance in equine 
gastrointestinal parasites.
Field studies indicate that PYR resistance is wide-
spread in equine intestinal nematodes in Europe and 
other regions. Previous studies have already shown that 
cyathostomin populations resistant to PYR are present in 
Table 1 The ivermectin and  pyrantel faecal egg count 
reduction classification using two different sets 
of methods
PYR, pyrantel, IVM, ivermectin
Drug class Method No. 1 Horse 
stud 
farms
















No resistance 19 Inconclusive 7
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the southern USA, with over 40% of farms demonstrat-
ing resistance to this drug [12]. Furthermore, resistance 
to PYR has been proven in two out of sixteen farms in 
Italy (12.5%) and suspected in one case (6.2%), with FECR 
values ranging from 43% to 85.4% [48]. Strongyles have 
been found to be resistant to pyrantel in Finland (43%), 
indicating widespread resistance [45]. Geographically 
near Lithuania, PYR-resistant populations of cyathos-
tomins have been found on Swedish horse farms, but 
the overall efficacy of PYR is still considered acceptable 
[18]. Lassen et  al. [17] have reported resistance to PYR 
in Estonia, with FECR of approximately 88% on four 
horse farms. These results are consistent with those 
found in this study. Resistance to PYR was detected on 
five farms (19%), with FECR calculated and interpreted 
in line with WAAVP recommendations. However, horses 
from only two of the five farms were still interpreted as 
having “resistance”, as recommended by Lyndal-Murphy 
et al. [29]. Cyathostomins were detected in larval cultures 
derived from strongyle positive faecal samples collected 
14 days after treatment with PYR. It should be noted that 
Pyrantel embonate (European Pharmacopeia) is consid-
ered synonymous with pyrantel pamoate (U.S. Pharma-
copeia). The label indications of these two pyrantel salts 
are virtually interchangeable at the same concentrations 
and dosages. In the USA, pyrantel pamoate is approved 
as a broad-spectrum equine anthelmintic at a dosage of 
6.6 mg/kg. However, certain formulations made by spe-
cific sponsors are also labelled for efficacy against equine 
tapeworms (Anoplocephala perfoliata) at a “3X” dosage 
of 19.8 mg/kg. This number is close to the pyrantel dos-
age (19 mg/kg) cited in the manuscript, and the prod-
uct name (Embotape) suggests that this formulation is 
labelled for efficacy against nematodes and tapeworms in 
horses. The doses in this study were based on the recom-
mendations of the European Pharmacopoeia and the dos-
ages given in the package leaflet, but a dose of 6.6 mg/kg 
should be considered in future because the actual pyran-
tel resistance situation in Lithuania could be significantly 
higher than that established in the present study.
This in vivo study showed that horse farms in Lithuania 
are already facing problems with AR, especially resistance 
to PYR. Despite the fact that resistance was found on five 
farms and in a small number of horses, an increase in AR 
can be expected in future. This demonstrates the need for 
regular parasite and anthelmintic susceptibility monitor-
ing and also the implementation of measures that would 
delay further development of AR on horse farms.
Infection followed by the development of AR can be 
controlled by correct administration of anthelmintic 
substances and a reduction in treatment frequency, e.g. 
by employing strict pasture management, as well as sta-
ble hygiene and farm management. For example, regular 
removal of manure from the pastures and systematic 
rotation of horses in paddocks and pens is recommended 
[49]. Yearly coprological examination is recommended to 
assess the quality and intensity of infection, as well as the 
efficacy of the management procedures [7].
Conclusions
The results of the FECRT with PYR revealed conclusive 
evidence of the presence of resistant cyathostomins on 
five farms (19%). As only very few horses were found to 
shed eggs 14 days after treatment, the efficacy of IVM 
was found to be very high on the Lithuanian horse farms 
studied. While resistance to IVM was not detected and 
PYR is not yet prevalent, the correct use of antihelmintic 
drug applications and continued monitoring of efficacy 
with FECRT is important for slowing down the develop-
ment AR in equine gastrointestinal parasites.
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